bromodeoxyuridine has been researched along with Cancer of Pancreas in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.34) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 8 (27.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bethge, S; Bobrowski, A; Mueller-Graf, F; Spitzner, M; Vollmar, B; Zechner, D | 1 |
| Chang, Y; Li, L; Li, X; Li, Z; Lv, F; Ma, W; Tian, T; Wang, X; Wu, J; Zhang, L; Zhang, M | 1 |
| Bremus-Köbberling, E; Feher, K; Junge, K; Klink, CD; Lambertz, A; Neumann, UP; Pich, A; Röth, A; Schmitz, D | 1 |
| Braun, D; Emmrich, J; Maletzki, C; Sturm, D | 1 |
| Amm, HM; Frost, AR; Johnson, MR; Novak, Z; Steg, A | 1 |
| Chang, Q; Chapman, MS; Hedley, DW; Miner, JN | 1 |
| Chang, Q; Do, T; Hedley, DW; Jurisica, I | 1 |
| Fahrig, R; Fahrig, T; Heinrich, JC; Schroeder, M; Tuukkanen, A | 1 |
| Barberi-Heyob, M; Didelot, C; Merlin, JL; Mirjolet, JF | 1 |
| Ensser, A; Hoggarth, JH; Jones, E; Meredith, DM | 1 |
| Bierkamp, C; Clerc, P; Dufresne, M; Fourmy, D; Lulka, H; Mathieu, A; Portolan, G; Pradayrol, L; Seva, C | 1 |
| Boeck, S; Fahrig, R; Hänel, M; Heinemann, V; Heinrich, JC; Krupitza, G; Liebert, A; Praha, C; Quietzsch, D; Schmid, RM; Sonntag, D | 1 |
| Al-Wadei, HA; Majidi, M; Schuller, HM | 1 |
| Chung, YS; Nakata, B; Sowa, M | 1 |
| Lawrence, TS; Robertson, JM; Shewach, DS | 1 |
| Ensminger, WD; Lawrence, TS; Robertson, JM; Walker, S | 1 |
| Inoue, M; Onda, M; Uchida, E | 1 |
| Baba, M; Iishi, H; Nakaizumi, A; Tatsuta, M; Uehara, H | 1 |
| Baba, M; Iishi, H; Iseki, K; Nakaizumi, A; Tatsuta, M; Uehara, H; Yano, H | 1 |
| Johansson, M; Karlsson, A; Zheng, X | 1 |
| Calbó, J; Cascalló, M; Fueyo, J; Gelpí, JL; Marotta, M; Mazo, A; Roig, JM | 1 |
| Hanahan, D; Lopez, T | 1 |
| Munzenrider, JE | 1 |
| Chung, YS; Nakata, B; Satake, K; Sawada, T; Sowa, M; Tanaka, H; Yokomatsu, H | 1 |
| Chung, YS; Kondo, Y; Kubo, T; Nakata, B; Satake, K; Sawada, T; Sowa, M; Yokomatsu, H | 1 |
| Kubota, Y; Moto-o, N; Nishimura, N; Saito, S; Taguchi, K; Tanaka, M; Watanabe, A; Yamazaki, K | 1 |
| Motoo, N; Nishimura, N; Saito, S; Taguchi, K; Yamazaki, K | 1 |
| Daido, T; Ito, A; Kiyoki, T; Shioaki, Y; Taniguchi, H | 1 |
| Clarkson, BD; Duschinsky, R; Keller, O; Krakoff, IH; La Sala, E; Van Dyk, JJ | 1 |
2 review(s) available for bromodeoxyuridine and Cancer of Pancreas
| Article | Year |
|---|---|
Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma.
Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Combined Modality Therapy; Deoxycytidine; Floxuridine; Fluorouracil; Gemcitabine; Idoxuridine; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1996 |
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
2 trial(s) available for bromodeoxyuridine and Cancer of Pancreas
| Article | Year |
|---|---|
RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bromodeoxyuridine; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation, Preclinical; Female; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Male; Middle Aged; Models, Molecular; Molecular Chaperones; Pancreatic Neoplasms; Pilot Projects; Placebos; Rats; Rats, Sprague-Dawley; Sarcoma; Survival Analysis | 2011 |
A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pancreatic Neoplasms; Radiotherapy Dosage | 1997 |
25 other study(ies) available for bromodeoxyuridine and Cancer of Pancreas
| Article | Year |
|---|---|
Risk factors for pancreatic ductal adenocarcinoma specifically stimulate pancreatic duct glands in mice.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Pancreatic Ductal; Ceruletide; Diabetes Mellitus, Type 2; Humans; Male; Metaplasia; Mice; Mice, Obese; Mucins; Neoplasm Proteins; Pancreatic Ducts; Pancreatic Neoplasms; Pancreatitis, Chronic; Risk Factors | 2013 |
Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression.
Topics: Analysis of Variance; Animals; Blotting, Western; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Cyclin D1; DNA Primers; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Mice; Mice, Inbred BALB C; Microarray Analysis; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay | 2013 |
Laser-induced drug release for local tumor control--a proof of concept.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; beta-Cyclodextrins; Bromodeoxyuridine; Cell Line, Tumor; Dimerization; Drug Delivery Systems; Fibroblasts; Flow Cytometry; Fluorouracil; Hydrophobic and Hydrophilic Interactions; Lasers; Palliative Care; Pancreatic Neoplasms; Solubility; Stents | 2014 |
cis-Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bromodeoxyuridine; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Hydroxyproline; Kinetics; L-Lactate Dehydrogenase; Leukocytes; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms | 2010 |
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; Gene Knockdown Techniques; Hedgehog Proteins; Humans; Inhibitory Concentration 50; Kruppel-Like Transcription Factors; Membrane Potential, Mitochondrial; Nerve Tissue Proteins; Pancreatic Neoplasms; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Veratrum Alkaloids; Zinc Finger Protein Gli3 | 2010 |
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Diphenylamine; Enzyme Inhibitors; Humans; Male; MAP Kinase Kinase Kinases; Mice; Neoplasm Transplantation; Pancreatic Neoplasms; Signal Transduction; Sirolimus; Sulfonamides | 2010 |
Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Differentiation; Cell Growth Processes; Cell Hypoxia; DNA, Neoplasm; Gene Expression Profiling; Genes, p53; Genes, ras; Humans; Mice; Mice, SCID; Microvessels; Mutation; Neoplasm Metastasis; Pancreatic Neoplasms | 2011 |
G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
Topics: Adenocarcinoma; Antimetabolites; Antimetabolites, Antineoplastic; Breast Neoplasms; Bromodeoxyuridine; Coloring Agents; Female; Flow Cytometry; Fluorouracil; G1 Phase; Head and Neck Neoplasms; Humans; Pancreatic Neoplasms; Propidium; Resting Phase, Cell Cycle; S Phase; Tumor Cells, Cultured | 2002 |
Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector.
Topics: Animals; Antiviral Agents; Aotidae; Base Sequence; Bromodeoxyuridine; Cells, Cultured; Colorectal Neoplasms; Ganciclovir; Genetic Vectors; Green Fluorescent Proteins; Humans; Jurkat Cells; K562 Cells; Kidney; Leukemia; Molecular Sequence Data; Pancreatic Neoplasms; Recombinant Fusion Proteins; Simplexvirus; Thymidine Kinase; Transfection | 2004 |
Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.
Topics: Adenoma; Animals; Antimetabolites, Antineoplastic; Azaserine; Bromodeoxyuridine; Carcinogens; Carcinoma, Acinar Cell; Cell Proliferation; Coloring Agents; Homeodomain Proteins; Homozygote; Immunohistochemistry; Inflammation; Lymphocytes; Mice; Mice, Transgenic; Pancreatic Neoplasms; Phenotype; Precancerous Conditions; Receptor, Cholecystokinin B; Receptors, G-Protein-Coupled; Risk; Time Factors; Trans-Activators; Transgenes | 2005 |
RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients.
Topics: Adult; Aged; Bromodeoxyuridine; Cell Line, Tumor; Cisplatin; Deoxycytidine; DNA-(Apurinic or Apyrimidinic Site) Lyase; Gemcitabine; Humans; Killer Cells, Natural; Middle Aged; Pancreatic Neoplasms | 2006 |
GABA B receptor is a novel drug target for pancreatic cancer.
Topics: Adrenergic beta-Agonists; Baclofen; Blotting, Western; Bromodeoxyuridine; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic AMP; Enzyme Activation; GABA Agents; GABA Agonists; gamma-Aminobutyric Acid; Humans; Immunohistochemistry; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pancreatic Neoplasms; Receptors, GABA; RNA Interference; Signal Transduction | 2008 |
A flow cytometric bromodeoxyuridine/DNA analysis for cytokinetics of the pancreatic cancer cell line Capan-2 after irradiation.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Count; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; Pancreatic Neoplasms; Tumor Cells, Cultured | 1993 |
[The significance of blood group-related antigen A in a pancreatic cell line (PGHAM-1) in hamsters. With special reference to cell proliferation].
Topics: ABO Blood-Group System; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; Cricetinae; Mesocricetus; Neoplasm Transplantation; Nitrosamines; Pancreatic Neoplasms; Tumor Cells, Cultured | 1997 |
d-Limonene inhibits N-nitrosobis(2-oxopropyl)amine induced hamster pancreatic carcinogenesis.
Topics: Animals; Apoptosis; Body Weight; Bromodeoxyuridine; Carcinoma; Cricetinae; Cyclohexenes; DNA Replication; Limonene; Male; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Terpenes | 1997 |
Inhibition by galanin of experimental carcinogenesis induced by azaserine in rat pancreas.
Topics: Animals; Anticarcinogenic Agents; Azaserine; Body Weight; Bromodeoxyuridine; Carcinogens; Galanin; Male; Norepinephrine; Organ Size; Pancreas; Pancreatic Neoplasms; Rats; Rats, Wistar | 1998 |
Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antiviral Agents; Arabinonucleosides; Bromodeoxyuridine; Catalysis; Cell Division; Cell Nucleus; Cladribine; Cytarabine; Deoxycytidine; Drosophila melanogaster; Gemcitabine; Humans; Inhibitory Concentration 50; Kinetics; Osteosarcoma; Pancreatic Neoplasms; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Promoter Regions, Genetic; Retroviridae; Substrate Specificity; Thymidine; Thymidine Kinase; Transduction, Genetic; Tumor Cells, Cultured | 2000 |
Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer.
Topics: Adenocarcinoma; Adenoviridae; Animals; Apoptosis; beta-Galactosidase; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Transfection; Tumor Cells, Cultured | 2001 |
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.
Topics: Animals; Apoptosis; beta-Glucosidase; Blotting, Western; Bromodeoxyuridine; Cadherins; Carcinoma, Islet Cell; Cell Division; Disease Progression; DNA-Binding Proteins; Flow Cytometry; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Invasiveness; Pancreatic Neoplasms; Receptor, IGF Type 1; Signal Transduction; Transcription Factors; Up-Regulation | 2002 |
[The effect of hyperthermia against pancreatic cancer cell--various examinations including flow cytometric bromodeoxyuridine/DNA analysis].
Topics: Animals; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Hyperthermia, Induced; Mice; Mice, Nude; Pancreatic Neoplasms; Tumor Cells, Cultured | 1992 |
Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Count; Cell Cycle; Cell Survival; Combined Modality Therapy; Culture Techniques; DNA, Neoplasm; Doxorubicin; Flow Cytometry; Humans; Hyperthermia, Induced; Pancreatic Neoplasms; Tumor Cells, Cultured | 1992 |
Cell-kinetic analysis of pancreatic cancers in Syrian golden hamsters.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cricetinae; Female; Immunohistochemistry; Kinetics; Male; Mesocricetus; Neoplasm Transplantation; Nitrosamines; Pancreatic Neoplasms; Tumor Cells, Cultured | 1991 |
[Cell kinetics of experimental pancreatic cancers in Syrian golden hamsters using intraperitoneal continuous bromodeoxyuridine infusion].
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cricetinae; Infusion Pumps; Infusions, Parenteral; Mesocricetus; Pancreatic Neoplasms | 1990 |
[The studies on the blood supply of metastatic liver tumor induced by VX2 using BrdU].
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Pancreatic Neoplasms; Rabbits | 1989 |
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Topics: Adenocarcinoma; Adult; Aged; Animals; Bromodeoxyuridine; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Colonic Neoplasms; Deoxyuridine; Dogs; Female; Floxuridine; Gallbladder Neoplasms; Gastrointestinal Neoplasms; Humans; Ileocecal Valve; Intestinal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Rectal Neoplasms; Sarcoma; Stomach Neoplasms | 1967 |